On Tuesday, Norwegian Cruise Line Holdings Ltd (NASDAQ:NCLH)’s shares declined -4.15% to $59.43.
Norwegian Cruise Line Holdings Ltd. (NCLH) together with NCL Corporation Ltd., “Norwegian Cruise Line Holdings”, “Norwegian” or the “Company”, stated financial results for the quarter ended June 30, 2015 and offered guidance for the third quarter and full year 2015.
Second Quarter 2015 Highlights
- Improvement in Adjusted EPS of 29.3% to $0.75 on Adjusted Net Income of $171.6 million.
- Enhance in Adjusted Net Yield on a Combined Company basis of 1.5%, or 3.2% on a Constant Currency basis, driven by pricing improvement in the quarter. Enhance of 18.2% on an as stated basis.
- Continued synergy identification efforts from the integration of Norwegian and Prestige lead to synergies of $75 million in 2015 and $125 million in 2016 preceding to reinvestment.
Norwegian Cruise Line Holdings Ltd., a cruise line operator, through its auxiliaries, provides cruise experiences for travelers with various itineraries. It offers cruises ranging from 1 day to 180 days. The company’s distribution channel comprises independent travel agents, wholesalers, and tour operators. It operates 21 ships under the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands with about 40,000 lower berths visiting about 430 destinations worldwide.
Aetna Inc (NYSE:AET)’s shares gained 1.08% to $115.02.
Aetna ( AET) declared second-quarter 2015 operating earnings (1) of $722.1 million, or $2.05 per share, a per-share enhance of 21 percent over the second quarter of 2014. Net income (2) for the second quarter of 2015 was $731.8 million, or $2.08 per share. Net income for the second quarter of 2015 comprises $0.03 per share of net benefits, which are detailed in the Summary of Results table on page 8.
Total company results
- Operating earnings (1)were $722.1 million for the second quarter of 2015 contrast with $610.0 million for the second quarter of 2014. The 18 percent enhance in operating earnings is primarily due to higher underwriting margins in Aetna’s Health Care segment, partially offset by an enhance in general and administrative expenses.
- Net income (2)was $731.8 million for the second quarter of 2015 contrast with $548.8 million for the second quarter of 2014. Net income in both periods reflects net benefits (charges), which are detailed in the Summary of Results table.
- Operating revenues(3) were $15.1 billion for the second quarter of 2015 contrast with $14.5 billion for the second quarter of 2014. The 4 percent enhance in operating revenues is primarily the result of higher Health Care premium yields in addition to membership growth in Aetna’s Government business partially offset by membership losses in Aetna’s middle-market Commercial Insured products. Total revenue was $15.2 billion and $14.5 billion for the second quarters of 2015 and 2014, respectively. Total revenue for the second quarter of 2015 comprises about $110 million of net litigation-related proceeds.
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit administration services, dental, behavioral health, and vision plans on an insured basis, and an employer-funded or administrative basis.
At the end of Tuesday’s trade, Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)‘s shares dipped -0.24% to $14.28.
Allscrip ts Healthcare Solutions, Inc. (MDRX) declared its financial results for the three and six months ended June 30, 2015.
Second-Quarter and Six-Month Bookings Highlights:
Bookings(1) were $260 million, a second-quarter record, contrast with $233 million in the second quarter of 2014, an 11 percent enhance. A higher mix of new client sales across Allscripts portfolio, counting acute solutions in both international and domestic markets, ambulatory and payer life sciences solutions, drove second quarter 2015 bookings performance on a year-over-year basis.
About 65 percent of second-quarter bookings related to software delivery, while the remaining 35 percent related to sales of client services. This compares with 58 and 42 percent of bookings attributable to these revenue categories, respectively, in the second quarter of 2014. Software delivery bookings raised 25 percent in the second quarter, year-over-year.
Allscripts Healthcare Solutions, Inc. provides clinical, financial, electronic health records (EHR), connectivity, hosting, outsourcing, analytics, patient engagement, and population health products and services in the United States and Canada. It operates in three segments: Clinical and Financial Solutions, Population Health, and Managed Services.
Vishay Intertechnology (NYSE:VSH), ended its Tuesday’s trading session with -4.43% loss, and closed at $10.79.
Vishay Intertechnology, (VSH), one of the world’s largest manufacturers of discrete semiconductors and passive components, recently declared its results for the fiscal quarter and six fiscal months ended July 4, 2015.
Revenues for the fiscal quarter ended July 4, 2015 were $590.5 million, contrast to $641.9 million for the fiscal quarter ended June 28, 2014. The net earnings attributable to Vishay stockholders for the fiscal quarter ended July 4, 2015 were $26.3 million, or $0.17 per diluted share, contrast to $35.6 million, or $0.23 per diluted share for the fiscal quarter ended June 28, 2014.
Net earnings attributable to Vishay stockholders for the fiscal quarter ended July 4, 2015 comprises restructuring and severance costs of $5.7 million. Net earnings attributable to Vishay stockholders for the fiscal quarter ended June 28, 2014 comprise restructuring and severance costs of $9.0 million. These items are summarized on the attached reconciliation plan. Adjusted earnings per diluted share, which exclude these items, were $0.20 and $0.27 for the fiscal quarters ended July 4, 2015 and June 28, 2014, respectively.
Vishay Intertechnology, Inc. manufactures and supplies discrete semiconductors and passive components in the United States, Europe, and Asia. The company operates in five segments: MOSFETs, Diodes, Optoelectronic Components, Resistors & Inductors, and Capacitors. The MOSFETs segment offers low- and medium-voltage TrenchFET MOSFETs, high-voltage planar MOSFETs, high voltage Super Junction MOSFETs, power integrated circuits, and integrated function power devices. The Diodes segment provides rectifiers, small signal diodes, protection diodes, thyristors/silicon-controlled rectifiers, and power modules.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
